Cargando…
H3.3 K36M Mutation as a Clinical Diagnosis Method of Suspected Chondroblastoma Cases
OBJECTIVE: Whether H3.3 K36M mutation (H3K36M) could be an approach if the diagnosis of chondroblastoma (CB) patients was indistinct and it was suspected to be unclear clinically. METHODS: We reviewed and compared our clinical experiences of CB cases and some suspected cases, which were not diagnose...
Autores principales: | Mu, Haoran, Jiang, Yafei, Xue, Linghang, Hua, Yingqi, Lin, Jun, Cai, Zhengdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957386/ https://www.ncbi.nlm.nih.gov/pubmed/33620145 http://dx.doi.org/10.1111/os.12878 |
Ejemplares similares
-
The incorporation loci of H3.3K36M determine its preferential prevalence in chondroblastomas
por: Zhang, Yanjun, et al.
Publicado: (2021) -
Personalized medicine modality based on patient-derived xenografts from a malignant transformed GCTB harboring H3F3A G34W mutation
por: Yafei, Jiang, et al.
Publicado: (2021) -
Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma
por: Voon, Hsiao P. J., et al.
Publicado: (2018) -
The diagnosis and treatment of tibial intercondylar chondroblastoma
por: Yang, Zhengming, et al.
Publicado: (2018) -
Subperiostial recurrence of chondroblastoma
por: Reddy, Sumanth, et al.
Publicado: (2015)